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Asynchronous Expression of the Homeodomain Protein CUX1 in Sertoli
Cells and Speratids During Spermatogenesis in Mice
Abstract
The homeodomain CUX1 protein exists as multiple isoforms that arise from proteolytic processing of a
200-kDa protein or an alternate splicing or from the use of an alternate promoter. The 200-kDa CUX1 protein
is highly expressed in the developing kidney, where it functions to regulate cell proliferation. Transgenic mice
ectopically expressing the 200-kDa CUX1 protein develop renal hyperplasia associated with reduced
expression of the cyclin kinase inhibitor p27. A 55-kDa CUX1 isoform is expressed exclusively in the testes.
We determined the pattern and timing of CUX1 protein expression in developing testes. CUX1 expression
was continuous in Sertoli cells from prepubertal testes but became cyclic when spermatids appeared. In testes
from mature mice, CUX1 was highly expressed only in round spermatids at stages IV–V of spermatogenesis, in
both spermatids and Sertoli cells at stages VI–X of spermatogenesis, and only in Sertoli cells at stage XI of
spermatogenesis. While most of the seminiferous tubules in wild-type mice were between stages VI and X of
spermatogenesis, there was a significant reduction in the percentage of seminiferous tubules between stages VI
and X in Cux1 transgenic mice and a significant increase in the percentage of seminiferous tubules in stages
IV–V and XI. Moreover, CUX1 was not expressed in proliferating cells in testes from either wild-type or
transgenic mice. Thus, unlike the somatic form of CUX1, which has a role in cell proliferation, the testis-
specific form of CUX1 is not involved in cell division and appears to play a role in signaling between Sertoli
cells and spermatids.
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ABSTRACT
The homeodomain CUX1 protein exists as multiple isoforms
that arise from proteolytic processing of a 200-kDa protein or an
alternate splicing or from the use of an alternate promoter. The
200-kDa CUX1 protein is highly expressed in the developing
kidney, where it functions to regulate cell proliferation.
Transgenic mice ectopically expressing the 200-kDa CUX1
protein develop renal hyperplasia associated with reduced
expression of the cyclin kinase inhibitor p27. A 55-kDa CUX1
isoform is expressed exclusively in the testes. We determined the
pattern and timing of CUX1 protein expression in developing
testes. CUX1 expression was continuous in Sertoli cells from
prepubertal testes but became cyclic when spermatids appeared.
In testes from mature mice, CUX1 was highly expressed only in
round spermatids at stages IV–V of spermatogenesis, in both
spermatids and Sertoli cells at stages VI–X of spermatogenesis,
and only in Sertoli cells at stage XI of spermatogenesis. While
most of the seminiferous tubules in wild-type mice were
between stages VI and X of spermatogenesis, there was a
significant reduction in the percentage of seminiferous tubules
between stages VI and X in Cux1 transgenic mice and a
significant increase in the percentage of seminiferous tubules
in stages IV–V and XI. Moreover, CUX1 was not expressed in
proliferating cells in testes from either wild-type or transgenic
mice. Thus, unlike the somatic form of CUX1, which has a role in
cell proliferation, the testis-specific form of CUX1 is not
involved in cell division and appears to play a role in signaling
between Sertoli cells and spermatids.
Sertoli cells, spermatid, spermatogenesis, testis
INTRODUCTION
The molecular mechanisms regulating mammalian sper-
matogenesis are not well understood. The process of
spermatogenesis is facilitated by Sertoli cells, which surround
developing germ cells and provide the appropriate milieu.
Sertoli cells function to create a niche for spermatogenesis,
which includes establishing the blood–testis barrier (BTB),
regulating the transition of spermatocytes through meiosis I
and II to form spermatids, and regulating the process of
spermiogenesis to form mature sperm [1, 2]. These functions
are facilitated by extensive cell–cell interactions between
adjacent Sertoli cells and between Sertoli cells and germ cells
[1, 3]. Cell–cell interactions, which include hemidesmosomes
[1–4], tight junctions [5–7], adherens junctions [1, 8], and gap
junctions [9, 10], undergo extensive restructuring to allow the
transit of primary spermatocytes across the BTB and the release
of spermatozoa into the tubular lumen [1, 11–13]. There are
numerous cell adhesion molecules involved in forming the
interactions between Sertoli cells and germ cells. These
molecules include immunoglobulin (Ig) superfamily members,
such as cell adhesion molecule 1 (CADM1) [14–18], poliovirus
receptor (PVR) [19], Nectin-2 [20], Nectin-3 [21], junctional
adhesion molecule JAM2 (also known as JAM-B [18, 22]), and
JAM3 (also known as JAM-C [23–24]), and non-Ig molecules,
such as cadherins and integrins [25–29]. During mouse
spermatogenesis, there is extensive junctional reorganization
corresponding to the release of mature sperm into the lumen of
the seminiferous tubule. At the same time, there is reorgani-
zation of the BTB, allowing the passage of primary
spermatocytes from the basal to the apical compartment [11].
This process is tightly regulated to ensure that these junctional
reorganizations occur simultaneously, thus maintaining the
seminiferous epithelial cycle [11].
The relationship between Sertoli cells and germ cells is
tightly regulated. Each Sertoli cell supports a fixed number of
germ cells [30, 31]. Thus, the number of Sertoli cells
determines the size of the testes and sperm production [30,
31]. The number of Sertoli cells in the adult testis is determined
early in development, and Sertoli cell proliferation is dependent
on the expression of the cyclin kinase inhibitors p21
(CDKN1A) and p27 (CDKN1B) [32]. Moreover, mice
carrying targeted mutations in CDKN1A and CDKN1B exhibit
increased numbers of Sertoli cells and enlarged testes [32].
CUX1 is a murine homologue of the Drosophila homeo-
domain cut protein and contains four DNA binding domains:
three cut repeats and the homeodomain [33–39]. The murine
cut homologues function as cell cycle-dependent transcription
factors, and CUX1 is part of the network controlling G
1
–S
transition, where it represses the expression of CDKN1A [40].
CUX1 also represses expression of CDKN1B, and transgenic
mice constitutively expressing CUX1 develop renal hyperpla-
sia, resulting from the aberrant repression of CDKN1B [41].
1Supported by NIH grant RO1 DK-58377 to G.B.V.H. and a summer
research training grant from the KUMC Office of Graduate Studies to
J.L. The University of Virginia Center for Research in Reproduction
Ligand Assay and Analysis Core is supported by Eunice Kennedy Shriver
NICHD/NIH (SCCPIR) grant U54-HD28934.
2Correspondence: FAX: 712 722 6035; e-mail: tjelsma@dordt.edu
3Correspondence: FAX: 913 588 2710;
e-mail: gvandenheuvel@kumc.edu
4These authors contributed equally to this study.
Received: 20 February 2010.
First decision: 31 March 2010.
Accepted: 12 October 2010.











These mice exhibit enlargement of several other organs,
including testes [41]. In addition to regulating the cell cycle,
CUX1 has been shown to regulate expression of E-cadherin
and N-cadherin and to stabilize SRC [42–43].
In addition to the CUX1 protein containing three cut repeats
and a homeodomain called p200, there are several truncated
isoforms that have been identified. These isoforms include a
testis-specific isoform containing one cut repeat and the
homeodomain called p55. In situ hybridization showed that
mRNA for p55 was most abundant in round spermatids [44].
Additional isoforms include p75, a protein similar in structure
to p55, derived from the use of an alternate promoter in intron
20 [45]; the cut alternately spliced protein (CASP), a Golgi
protein that contains amino-terminal sequences but none of the
cut repeats or homeodomains [46]; and several other isoforms
(p80, p90, p110, and p150) that appear to arise via proteolytic
processing [47, 48]. While p200 functions exclusively as a
transcriptional repressor, the transcriptional mechanism used
by the other CUX1 isoforms is more complex. Isoforms p75,
p90, and p110 can function either as repressors or activators of
transcription, depending on the promoter context, while p80
functions exclusively as an activator. The p150 isoform does
not bind DNA but instead acts as a dominant negative in the
mammary gland during lactation [48]. In the present study, we
examined the expression of CUX1 protein in prepubertal and
adult testes from wild-type and Cux1 transgenic mice to
correlate CUX1 expression with the stages of spermatogenesis




Cux1 transgenic mice expressing full-length Cux1 cDNA under the control
of the cytomegalovirus (CMV) immediate-early gene promoter were generated
previously [41]. Genotyping was performed by Southern blot analysis of tail
DNA after digestion with appropriate restriction nucleases or by PCR analysis
using a 50 primer specific for the CMV promoter and a 30 primer specific for the
Cux1 cDNA. Age-matched wild-type littermates were used as controls. Mice
were maintained in accordance with the Institutional Animal Care and Use
Committee at the University of Kansas Medical Center.
Immunohistochemistry Analysis
Immunohistochemistry analysis was performed as previously described
[49]. Briefly, isolated testes were immersion-fixed in 4% paraformaldehyde and
blocked in paraffin. Three-micrometer -thick sections were deparaffinized with
xylene and hydrated with concentration-graded ethanol. Sections were washed
in PBS containing 1% Tween 20 (PBST) and blocked in 10% normal goat
serum at room temperature for 1 h. Rabbit anti-CUX1 (product no. sc-13024;
Santa Cruz Biotechnology), mouse anti-PCNA (product no. p-8825; Sigma),
rabbit anti-WT1 (product no. sc-192; Santa Cruz Biotechnology), or rat anti-
germ cell nuclear antigen (GCNA) primary antibody [50] was applied to
sections and incubated at room temperature for 1 h at final concentrations of
1:100, 1:3000, 1:100, and undiluted, respectively. Biotinylated goat anti-rabbit
(1:400) antibody was used to detect CUX1 and WT1 antibody. A horse anti-
mouse-Texas Red-conjugated secondary antibody (Vector) was used to detect
PCNA (1:400). A goat anti-rat-Texas Red-conjugated secondary antibody
(Vector) was used to detect GCNA (1:400). Sections were then washed in
PBST and incubated with either fluorescein isothiocyanate-conjugated avidin
(Vector) or with avidin-biotin-peroxidase complex (ABC Elite; Vector) and
diaminobenzidine (DAB). In some cases, following DAB incubation, sections
were counterstained with periodic acid-Schiff (PAS) stain (American Master
Tech). All sections were washed and then either mounted with Vectashield
medium with 40,60-diamidino-2-phenylindole (DAPI) (Vector) or dehydrated
with graded ethanols, mounted with Permount (Fisher), and covered with glass
coverslips. Images were captured using Nomarski differential interference
contrast with a Leica DMR model microscope equipped with an Optronics
Magnafire digital camera or by using an Olympus BH-2 microscope equipped
with an Olympus DP71 digital camera.
Morphometry Analysis
The tubule’s minimum cross-sectional distance was taken as the diameter,
to account for obliquely cut sections [51]. The cross-sectional area (A) of the
seminiferous tubule was calculated by dividing the average diameter for each
tubule to obtain the radius and then multiplying p times the radius squared (A¼
pr2). The density of Sertoli cells in seminiferous tubules was calculated by
dividing the number of WT1-positive cells by the estimated circumference of
the tubule (average of minimum and maximum diameter3 p) from over 100
seminiferous tubules in testes sections from at least two animals of each
genotype [52–55]. To quantify the percentage of seminiferous tubules
expressing CUX1 in Sertoli cells only, in Sertoli cells and spermatids, in
spermatids only, or in neither Sertoli cells nor spermatids, the number of
tubules exhibiting these patterns were counted in three testis sections from three
animals of each genotype. All morphometry analysis was performed in a
blinded fashion. Data are presented as means 6 SD. The cross-sectional area,
the density of Sertoli cells, and the percentage of seminiferous tubules
expressing CUX1 were analyzed by Student t-test. Differences were considered
significant at a P value of ,0.05. Interstitial cell counts were obtained from
hematoxylin-eosin-stained 5-lm sections of testis sections from four Postnatal
Day-14 (P14) and P35 transgenic and wild-type mice. Photomicrographs were
taken at 2003 original magnification, and the number of interstitial cell nuclei
in 10 medium power fields from each sample was counted. Data were analyzed
by Student t-test.
Western Blot Analysis
Nuclear extracts (30 lg) were separated by electrophoresis on 4–15%
gradient polyacrylamide gels and transferred to nitrocellulose membranes,
where they were blocked in 5% milk-PBST, as previously described [49].
Membranes were probed with rabbit anti-CUX1 (product no. sc-13024; Santa
Cruz Biotechnology) primary antibody at a dilution of 1:50, followed by
washes with PBST and application of horseradish peroxidase (1:10 000)
secondary antibody. Following additional washes with PBST, bound antibody
was detected by chemiluminescence (Pierce) according to the manufacturer’s
directions.
Testosterone and Follicle-Stimulating Hormone Assays
Blood was collected from 4-week-old wild-type (n ¼ 4) and Cux1
transgenic (n ¼ 3) mice and from 6-month-old wild-type (n ¼ 4) and Cux1
transgenic (n ¼ 3) mice prior to being euthanized, and isolated serum was
delivered to the University of Virginia Center for Research in Reproduction
Ligand Assay and Analysis Core for analysis of serum testosterone and follicle-
stimulating hormone (FSH). Results were compared using the Student t-test for
paired samples.
TUNEL Assay
Sections were processed for terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate nick-end labeling (TUNEL) with a
TUNEL apoptosis detection kit (Millipore) according to the manufacturer’s
directions. Sections were mounted with Vectashield medium with DAPI
(Vector) and covered with glass coverslips. Images were captured with a Leica
DMR model microscope equipped with an Optronics Magnafire digital camera.
RESULTS
We previously described a testis-specific Cux1 mRNA
transcript of 2.4 kb encoding a 55-kDa protein that was
primarily expressed in postmeiotic round spermatids (44). We
also showed that a 13-kb Cux1 transcript corresponding to the
full-length 200-kDa protein was expressed in testes from mice
homozygous for the atrichosis (at/at) mutation, which lacks
germ cells (44). This somatic isoform is expressed in many
other tissues, including the kidney. Transgenic mice constitu-
tively expressing the full-length isoform of CUX1 develop
multiorgan hyperplasia, including an increase in the size of the
testes [41]. To determine whether the expression of the testis
CUX1 protein is altered in transgenic mice, we evaluated
CUX1 protein expression in postpubertal testes isolated from
wild-type and transgenic mice. Using an antibody directed to
the C terminus of CUX1, which is shared between somatic- and
testis-specific isoforms of the CUX1 protein, we evaluated








CUX1 protein expression in testes from wild-type and Cux1
transgenic mice. In testes from sexually mature (35 days
postpartum [p.p.]) wild-type mice, we observed CUX1 protein
expression in spermatids and in Sertoli cells. Moreover,
expression in both cell types varied between tubules, giving
four different patterns consisting of one, both, or neither cell
type expressing CUX1 (Fig. 1). Using periodic acid-Schiff
(PAS) staining following immunohistochemical labeling for
the CUX1 protein, we correlated the four CUX1 expression
patterns with spermatid morphology [56, 57]. We found very
little expression of the CUX1 protein in either Sertoli cells or
spermatids at stages I–III (Fig. 2A). This finding was consistent
with that of our previous studies evaluating Cux1 mRNA in
postpubertal testes by in situ hybridization [44]. At stages IV–
V, we observed expression of the CUX1 protein only in round
spermatids (Fig. 2B). Again, this pattern of protein expression
paralleled that of the mRNA expression previously reported
[44]. Beginning at stage VI and continuing through stage VIII,
FIG. 1. Expression of CUX1 protein in adult testis. Paraffin sections of
testes from P35 mice were labeled with antibodies directed against CUX1
(green) and PCNA (red) and counterstained with DAPI (blue) to identify
nuclei. Fluorescent images were merged with differential interference
contrast images to show tissue architecture. Immunofluorescence labeling
showed CUX1 protein localization in Sertoli cells (arrowheads) and in
spermatids (arrows). Four different CUX1 labeling patterns of CUX1
labeling are shown in which CUX1 is not expressed (1); CUX1 is
expressed only in spermatids (2); CUX1 is expressed in both spermatids
and Sertoli cells (3); and CUX1 is expressed only in Sertoli cells (4).
Original magnification3400.
"
FIG. 2. Expression of CUX1 is asynchronous in seminiferous tubules in
postpubertal testes. Following immunohistochemical labeling for CUX1
protein, testis sections were counterstained with PAS stain to identify
stages of spermiogenesis. A) There is no significant CUX1 expression in
seminiferous tubules at stages I–III, which is characterized by a double
layer of round spermatids, which exhibit 1–3 preacrosomal granules that
do not touch the cell membrane (filled arrows), and elongated spermatids
(open arrows). B) CUX1 is expressed only in round spermatids in
seminiferous tubules at stages IV–V, which are characterized by the PAS-
positive granule touching the membrane, which does not bend to conform
to the shape of the nucleus (arrow). No CUX1 expression is observed in
Sertoli cells. C) At stages VI–VIII, indicated by round spermatids in which
the PAS-positive acrosome forms a cap that spreads over the nucleus and
is, in some cases, oriented toward the basal membrane of the tubule,
CUX1 is highly expressed in both round spermatids (arrows) and Sertoli
cells (arrowheads). D) At stages IX–X, indicated by elongation of the
spermatid nuclei, CUX1 continues to be highly expressed in both
elongating spematids (arrows) and Sertoli cells (arrowheads). E) At stage
XI, indicated by compacted and darkly stained spermatid heads (arrows),
CUX1 is expressed only in Sertoli cells (arrowheads). Original magnifi-
cation3630.








we observed intense expression of CUX1 in both round
spermatids and Sertoli cells (Fig. 2C).
Although we previously reported Cux1 mRNA expression
in round spermatids in stage VI–VIII tubules, we had not
observed Cux1 mRNA expression in Sertoli cells [44]. At
stages IX–X, we observed CUX1 protein in both elongating
spermatids and Sertoli cells (Fig. 2D). The expression of CUX1
protein in elongating spermatids contrasts with that of the
previous study, in which Cux1 mRNA was not observed in
elongating spermatids at stage IX or X [44]. Finally, at stage
XI, the CUX1 protein was detected only in Sertoli cells, with
no expression in the spermatids (Fig. 2E). This is consistent
with the absence of Cux1 mRNA in spermatids in seminiferous
tubules at stages IX–XI, as described previously [44].
Differences in Cux1 mRNA expression levels previously
reported and in the pattern of CUX1 protein expression
suggest that the translated protein remains in maturing
spermatids after mRNA is degraded.
To determine when the differential expression of CUX1
begins during testis development, we evaluated CUX1
expression with prepubertal testes (Fig. 3). In testes sections
from 7-day-old mice, CUX1 protein was uniformly expressed
in most cells of the seminiferous tubules (Fig. 3A). This
uniform pattern of expression continued at 14 days p.p. (Fig.
3B). At 21 days p.p., a differential pattern of CUX1 expression
was observed, revealing the four patterns of expression
observed in adult mice (Fig. 3C). This pattern of expression
was also observed at 28 and 35 days p.p. (Fig. 3D and Fig. 1).
To determine whether CUX1 was also expressed in spermato-
gonia, we colabeled testis sections from 21- and 35-day-old
FIG. 3. Asynchronous CUX1 expression is
associated with the appearance of round
spermatids. Paraffin sections of testes iso-
lated from Day-7, -14, -21, and -28 p.p.
mice were labeled with antibody against
CUX1. CUX1 is continuously expressed in
Sertoli cells in the developing testis from P7
(A) and P14 (B) mice. In contrast, CUX1
expression is asynchronous in testis from
P21 (C) and P28 (D) mice, showing the four
different patterns of CUX1 labeling in which
CUX1 is not expressed (1); CUX1 is
expressed only in spermatids (2); CUX1 is
expressed in both spermatids and Sertoli
cells (3); and CUX1 is expressed only in
Sertoli cells (4). Original magnification
3200 (A, B) and 3100 (C, D).
FIG. 4. CUX1 is not expressed in sper-
matogonia. Paraffin sections of testes iso-
lated from Day-21 and Day-35 p.p. mice
were labeled with antibodies directed
against CUX1 and GCNA, a marker ex-
pressed in all spermatogonia, spermato-
cytes, and round spermatids. At P21, CUX1
is expressed in cells at the periphery of the
seminiferous tubules (A, C), which do not
express GCNA (B, C), indicating that they
are not germ cells. At P35, CUX1 (D, F,
arrows) is expressed in cells between
GCNA-positive spermatogonia (E, F, ar-
rowheads), indicating that CUX1 is ex-
pressed in Sertoli cells (F). Original
magnification 3400.








mice with antibodies directed against CUX1 and GCNA, an
antigen expressed in all diploid spermatogonia, as well as in
spermatocytes and round spermatids [50]. Figure 4 shows
CUX1 and GCNA were expressed in mutually exclusive
patterns at the periphery of the seminiferous tubules of both 21-
day p.p. and 35-day p.p. mice, indicating that CUX1 is not
expressed in spermatogonia. To correlate the differential
patterns of CUX1 expression with the sizes of the CUX1
proteins, we performed Western blot analysis with testes
isolated from 7-day-old mice, when CUX1 is uniformly
expressed in seminiferous tubules, and with testes isolated
from 28-day-old mice, after a differential pattern of CUX1
expression is observed. At 7 days p.p., the most abundant
CUX1 protein is the p200 somatic form, with no detectable
expression of p55 (Fig. 5A). In contrast, at 28 days p.p., the
most abundant CUX1 proteins are p55 and p75, with relatively
lower levels of p200 (Fig. 5B).
We previously showed that testes isolated from Cux1
transgenic mice were increased in size by ;25% at 6 weeks of
age, although differences in size between the Cux1 transgenic
and wild-type mice were less evident as the mice aged [41]. To
determine whether spermatogenesis is altered in mice consti-
tutively expressing the somatic isoform of CUX1, we evaluated
CUX1 expression in testes isolated from wild-type and Cux1
transgenic mice. Testes sections from both wild-type and Cux1
transgenic mice showed the same differential patterns of
expression between Sertoli cells and spermatids during
spermatogenesis (Fig. 6). To determine whether the increase
in overall testis size resulted from an increased size of
seminiferous tubules, we measured the cross-sectional areas
of individual seminiferous tubules from three wild-type and
three Cux1 transgenic mice. A comparison between the cross-
sectional areas of individual seminiferous tubules from wild-
type and that of transgenic mice revealed no significant
differences (wild-type, 3.34 3 105 lm2 vs. transgenic, 3.563
105 lm2; P ¼ 0.57, n ¼ 144). Full-length CUX1 protein
regulates the cell cycle by repressing the cyclin kinase
inhibitors CDKN1A1 and CDKN1B [40, 41]. We have
previously shown that renal hyperplasia in Cux1 transgenic
mice resulted from repression of CDKN1B [41]. Moreover,
mice carrying targeted deletions of Cdkn1b and Cdkn1a show
an increase in the number of Sertoli cells resulting from
increased proliferation [32]. As CUX1 functions to regulate the
cell cycle by repressing CDKN1A and CDKN1B during
kidney development, one possibility is that the increase in testis
size resulted from an increased number of Sertoli cells. To
determine whether Sertoli cell proliferation was increased in
Cux1 transgenic testes, we evaluated the density of Sertoli cells
in the seminiferous tubules of 35-day p.p. wild-type and Cux1
FIG. 5. CUX1 (p55) is not expressed until after the appearance of round
spermatids. Western blotting of nuclear extracts (30 lg) isolated from
testes of 7-day p.p. (P7) and 28-day p.p. (P28) mice. A) Testes from P7
mice express high levels of the CUX1 (p200) protein, corresponding to
continuous Sertoli cell expression. No expression of the truncated CUX1
(p55) protein is observed in P7 testes. B) Testes from P28 mice express
high levels of the CUX1 (p55) protein, corresponding to the appearance of
round spermatids. Expression of the CUX1 (p75) protein is also detected in
P28 testes. The expression of CUX1 (p200) is much lower in P28 testes,
corresponding to asynchronous expression in Sertoli cells.
FIG. 6. Asynchronous CUX1 expression in testes from both wild-type
and Cux1 transgenic mice is not associated with cell proliferation. Testes
sections from 35-day p.p. wild-type (A, C, E, G, I) mice and Cux1
transgenic (B, D, F, H, J) mice were colabeled with antibodies directed
against CUX1 (green) and PCNA (red) to identify proliferating cells.
Sections were then counterstained with DAPI. Seminiferous tubules
corresponding to the indicated stages of spermatogenesis are outlined.
CUX1 and PCNA did not colocalize at any stage of spermatogenesis in
either wild-type or transgenic mice, indicating that CUX1 expression in
either Sertoli cells or spermatids does not regulate cell proliferation.
Original magnification3630.








transgenic mice. Testis sections were labeled with WT1
antibody to identify Sertoli cells, and the number of WT1-
positive cells/circumferences of seminiferous tubules were
determined. We found no difference in numbers of Sertoli cells
between the wild-type and the transgenic mice (wild-type,
0.047 6 0.008 SD vs. transgenic, 0.044 6 0.007 SD cells per
micrometer of circumference; n ¼ 144).
In the kidneys of Cux1 transgenic mice, ectopic expression
of CUX1 results in increased cell proliferation, concomitant
with reduced expression of the cyclin kinase inhibitor
CDKN1B [41]. To determine whether CUX1 regulates cell
proliferation during testis development, we colabeled testis
sections from wild-type and Cux1 transgenic mice with
antibodies directed against CUX1 and PCNA. As expected,
CUX1 and PCNA did not colocalize in the postmeiotic round
spermatids of either wild-type or Cux1 transgenic mice (Fig. 6).
To determine whether the ectopic expression of CUX1 had an
affect on the pattern of CUX1 expression in adult testes, we
evaluated the percentage of seminiferous tubules exhibiting
each of the four patterns of expression. We found a significant
shift in the percentage of seminiferous tubules in three of the
four patterns of CUX1 expression (Fig. 7). In Cux1 transgenic
mice, there was a significant increase in the number of tubule
profiles that showed Sertoli or spermatid expression only and a
significant decrease in the number of tubule profiles that
showed both Sertoli and spermatid expression of CUX1. While
there was an increase in the number of tubules that did not
show any expression of CUX1, the increase did not reach
significance and represented only a small percentage of tubules
in either wild-type or transgenic mice.
Because Sertoli cells do not proliferate in mature testes, we
compared patterns of CUX1 expression during testis develop-
ment between wild-type and Cux1 transgenic mice. CUX1 and
PCNA did not colocalize at any stage of development during
spermatogenesis, either in wild-type or Cux1 transgenic mice
(Figs. 6 and 8 and Supplemental Figs. S1 and S2, available
online at www.biolreprod.org). Thus, unlike in the developing
kidney, CUX1 does not appear to play a role in promoting cell
proliferation in the developing testis. At the earliest stages of
testis development (7, 10, and 14 days p.p.), patterns of CUX1
and PCNA expression were unchanged between wild-type and
Cux1 transgenic mice (Supplemental Fig. S1). In contrast,
while testes from Day-21 p.p. wild-type mice showed the
switch to the differential pattern of CUX1 expression (Fig. 8A),
FIG. 7. Percentage of seminiferous tubules expressing CUX1 protein is
altered in testes from Cux1 transgenic mice. The number of seminiferous
tubules expressing CUX1 only in spermatids, in spermatids and Sertoli
cells, only in Sertoli cells, or in neither were scored in a blinded fashion
using testes sections from three 35-day p.p. wild-type (gray bars) mice and
three 35-day p.p. Cux1 transgenic (black bars) mice. There was a
significant increase in the percentage of seminiferous tubules expressing
CUX1 only in spermatids and only in Sertoli cells and a significant
decrease in the percentage of seminiferous tubules expressing CUX1 in
both spermatids and Sertoli cells in the Cux1 transgenic mice compared to
that of wild-type mice. Error bars indicate standard deviation.
FIG. 8. Asynchronous expression of CUX1
is delayed in Cux1 transgenic (TG) mice.
Testes sections from 21-day p.p. and 35-day
p.p. wild-type (WT) and Cux1 transgenic
mice were labeled with antibodies directed
against CUX1 (green) and PCNA (red),
followed by counterstaining with DAPI
(blue). At 21 days p.p., wild-type mice show
asynchronous expression of CUX1 in sper-
matids (arrows) and Sertoli cells (arrow-
heads) (A). In contrast, Cux1 transgenic
mice show continuous expression of CUX1
in Sertoli cells at the periphery of the
seminiferous tubules (B). At 35 days p.p.,
both wild-type (C) and Cux1 transgenic (D)
mice showed asynchronous expression of
CUX1 in spermatids and Sertoli cells. There
is no overlap of CUX1 and PCNA expres-
sion at any stage of spermatogenesis.
Original magnification 3400.








testes from Day-21 p.p. transgenic mice showed a more
uniform CUX1 expression pattern, with no expression in
spermatids and high expression in cells at the periphery of the
tubules, consistent with the Sertoli cell expression (Fig. 8B).
By Day 28 and Day 35, the expression patterns of CUX1 of
wild-type mice were similar to that of transgenic mice, with
both showing the differential pattern of CUX1 expression (Fig.
8C, D, and Supplemental Fig. S2). This suggests that CUX1
expression in Sertoli cells functions to regulate the switch to
the differential expression pattern and that ectopic expression
of CUX1 delays this switch.
The hormone testosterone is required for spermatogenesis,
and changes in testosterone levels can dramatically affect the
development of sperm cells [58]. Accordingly, we evaluated
serum testosterone levels in wild-type and Cux1 transgenic
mice before and after sexual maturity (Fig. 9A). We observed
levels of serum testosterone that were similar for wild-type and
Cux1 transgenic mice at 4 weeks of age, prior to sexual
maturity. In contrast, there was a significant increase in serum
testosterone in 6-month-old Cux1 transgenic mice compared to
that of age-matched wild-type mice (Fig. 9A). In addition to
testosterone, the hormone FSH can also influence spermato-
genesis [59]. Thus, we evaluated serum FSH levels in 4-week-
old and 6-month-old wild-type and Cux1 transgenic mice. In
contrast to the testosterone levels, no differences in FSH were
observed in Cux1 transgenic mice before or after sexual
maturity (Fig. 9B).
The primary producer of testosterone is the interstitial
Leydig cell. To determine if there was a difference in the
number of Leydig cells, which could account for the increase in
testosterone, we counted the number of interstitial cells in testis
sections from Day-14 and Day-35 p.p. wild-type and Cux1
transgenic mice (Table 1). There was a significant increase in
the number of interstitial cells in Cux1 transgenic mice at Day
14 p.p. compared to that in wild-type mice. In contrast, there
was no difference between the number of interstitial cells at 35
days p.p. in wild-type mice and that in Cux1 transgenic mice.
Finally, apoptosis occurs normally in spermatogenesis. To
determine whether apoptosis was disrupted in Cux1 transgenic
mice, we performed TUNEL assays of 35-day p.p. wild-type
and Cux1 transgenic mice. No differences in the number of
TUNEL-positive cells were observed between wild-type and
Cux1 transgenic mice (Fig. 10).
DISCUSSION
Themurine Cux1 homeobox gene is related to the
Drosophila cut gene. We have previously identified a testis-
specific isoform of CUX1 that is expressed beginning at P21 in
postmeiotic round spermatids [44]. The 2.4-kb mRNA
encoding the testis-specific 55-kDa CUX1 isoform likely
results from the use of an alternate promoter. An alternate
promoter in intron 20 has been identified in the generation of
the CUX1 (p75) protein. Since p55 and p75 have similar
structures, it is possible that the same promoter is used to
generate both transcripts. Moreover, the amino acid sequence
of the 55-kDa protein is identical to the corresponding region
of the larger CUX1 protein. This larger protein is translated
from a 13-kb transcript that is highly expressed in many
different tissues during development. In the kidney, the 200-
kDa CUX1 protein is most highly expressed in the nephrogenic
zone, where cells are actively proliferating, but is sharply
downregulated coincident with exit from the cell cycle [38, 41].
To determine whether downregulation of the larger protein is
required for normal kidney development, we constitutively
expressed cDNA expressing the 200-kDa CUX1 protein in
transgenic mice, using the CMV immediate-early gene
promoter. The Cux1 transgenic mice exhibited enlarged organs,
including the testis, and in the kidney, this resulted from
aberrant repression of the cyclin kinase inhibitor CDKN1B
[41]. Recently, we have determined that CUX1 functions to
repress CDKN1B during kidney development in cooperation
with the groucho homologue GRG4 (official symbol TLE4)
[60]. To determine whether the increase in testis size that we
observed in Cux1 transgenic mice resulted from repression of
CDKN1B and/or whether expression of the testis-specific
CUX1 protein was disrupted, we evaluated expression of the
CUX1 protein in testes isolated from wild-type and Cux1
transgenic mice.
The number of Sertoli cells in the adult testis determines the
size of the testis and the sperm production [30–32]. Moreover,
each Sertoli cell supports a relatively fixed number of germ
cells [30]. Mice carrying a targeted Cdkn1b deletion show an
increase in testis size that results from an increase in Sertoli cell
proliferation [32]. Because CUX1 functions to repress the
Cdkn1b gene expression in developing kidneys and Cux1
transgenic mice develop renal hyperplasia from the aberrant
FIG. 9. Increased testosterone in Cux1 transgenic mice. Total serum
testosterone (A) or FSH (B) levels from wild-type and Cux1 transgenic mice
at 4 weeks and 6 months of age were measured by radioimmunoassay.
Serum testosterone was significantly increased in 6-month-old Cux1
transgenic mice compared to wild-type mice (A). Error bars indicate
standard deviation. *, P ¼ 0.0198.
TABLE 1. Interstitial cell counts.a
Day Wild type Transgenic Relative increase (%)
P14 203 (11) 243 (13)* 20
P35 163 (6) 160 (10) 0
a Data are expressed as group means of the number of interstitial cells per
field; standard error is indicated in parentheses (*P¼ 0.046).








repression of CDKN1B, one possibility for the increased size
of testes in the Cux1 transgenic mice was an increase in the
number of Sertoli cells. However, a comparison of the numbers
of Sertoli cells in transgenic versus those in wild-type mice
showed no differences. Moreover, CUX1 expression did not
colocalize with PCNA in cells in the testes in either wild-type
or transgenic mice, even at the stages of development when
Sertoli cells proliferate, suggesting that CUX1 does not
function to regulate the cell cycle during spermatogenesis.
Using an antibody directed against the C-terminal end of
CUX1, which recognizes both the 200-kDa and the 55-kDa
CUX1 isoforms, we observed CUX1 expression in both Sertoli
cells and spermatids in sexually mature wild-type mice.
However, unlike other genes expressed in Sertoli cells, such
as the Wt1 [61] and Rbl2 p130 [62] genes, the Cux1 gene gave
a phasic and stage-specific pattern of expression in spermatids
and Sertoli cells of mature testes. This expression pattern
varied between seminiferous tubules, with one, both, or neither
cell type expressing CUX1. Using published criteria based on
spermatid morphology to classify the seminiferous tubules
[56–57], we found these patterns of CUX1 expression
corresponded to stages I–III of spermatogenesis (neither
spermatid nor Sertoli cell expression), stages IV–V of
spermatogenesis (spermatid expression only), stages VI–VIII
(both round spermatids and Sertoli cell expression), stages IX–
X (both elongating spermatids and Sertoli cell expression), and
stage XI (Sertoli cell expression only). Prior to P21, CUX1
expression was continuous in Sertoli cells and not expressed in
developing germ cells, consistent with the expression of
mRNA previously reported. At P21, CUX1 was observed in
spermatids, and this expression was associated with the change
to the phasic, stage-specific pattern of expression. The change
in CUX1 expression in Sertoli cells, from continuous in
prepubertal mice to phasic when spermatids are first present at
P21, suggests that there is negative feedback from the
spermatids to the Sertoli cells, suppressing CUX1 expression
in the latter. Alternatively, the downregulation of CUX1
expression in Sertoli cells may be required for expression in
round spermatids. In contrast to that of wild-type mice, CUX1
expression was continuous in the Sertoli cells of testes isolated
from P21 Cux1 transgenic mice, which did not show the switch
to asynchronous expression until P28. This suggests that forced
expression of CUX1 in the Sertoli cells slowed the initial
spermatogenic cycle or that it temporarily prevented the
expression of CUX1 protein in round spermatids.
At stage VIII of spermatogenesis, there is junctional
reorganization that permits the release of mature sperm into
the lumens of seminiferous tubules [1, 3, 11–13]. The BTB is
concurrently reorganized, permitting the movement of primary
spermatocytes into the apical compartment. During stage VIII
of mouse spermatogenesis, there is intense CUX1 expression in
both round spermatids and Sertoli cells. In testes from wild-
type mice, more than 60% of the seminiferous tubules showed
CUX1 expression in both spermatids and Sertoli cells,
consistent with their being between stages VI and X. However,
in the testes from Cux1 transgenic mice, there was a significant
reduction in the percentage of tubules showing CUX1
expression in both spermatids and Sertoli cells, with a
significant increase in the percentage of tubules showing
CUX1 expression in only spermatids or Sertoli cells. This
suggests either that progression through stages VI–X of
spermatogenesis is accelerated in the transgenic testes or that
the rate of progression through the other stages is reduced.
CUX1, in cooperation with transcription factors snail and
slug, has recently been shown to regulate the expression of E-
cadherin and N-cadherin [42]. Moreover, CUX1 was able to
repress the expression of E-cadherin and activate the
expression of N-cadherin. Thus, one possibility is that CUX1
normally functions in Sertoli cells to regulate the expression of
N-cadherin, an integral membrane protein of the BTB.
However, the reorganization of junctions that occurs during
spermatogenesis results primarily from endocytosis and
recycling of membrane proteins that form the junctions [11,
63, 64]. CUX1 has also been shown to stabilize SRC through
FIG. 10. Cux1 transgenic mice do not
show increased apoptosis. Similar numbers
of TUNEL-positive cells were observed in
testis sections isolated from 35-day p.p.
wild-type (A, B) and Cux1 transgenic (C, D)
mice. Arrows indicate TUNEL-positive
cells. Arrowheads indicate autofluorescent
red cells. Original magnification 3400.








upregulation of C-terminal Src kinase (CSK) [43]. In
spermatogenesis, SRC functions to phosphorylate N-cadherin
and b-catenin, leading to the release of mature sperm [58, 65,
66]. Moreover, SRC is most abundant at stages VI–VIII of
spermatogenesis, and both SRC and CSK are found to
associate with both Sertoli cells and spermatids at this stage
[65]. Thus, upregulation of CUX1 in Sertoli cells beginning at
stage VI may be involved in stabilizing SRC, triggering the
release of sperm in stage VIII. One possibility is that increased
expression of CUX1 in transgenic mice results in increased
CSK and SRC and an altered rate of progression through
spermatogenesis. In addition, testosterone activation of Sertoli
cells results in increased SRC phosphorylation [67]. Thus,
another possibility is that the increase in testosterone in the
Cux1 transgenic mice increases SRC activity, resulting in an
altered rate of progression through spermatogenesis. The
importance of SRC in spermatogenesis has been demonstrated
in vivo using the SRC inhibitor PP1 [65]. Inhibition of SRC
resulted in a disruption of interactions between Sertoli cells and
round spermatids and spermatocytes, leading to the loss of
these germ cells. In contrast, there was no observable change in
the morphology of seminiferous epithelium or apparent affect
on fertility of the Cux1 transgenic mice. Moreover, the
targeted deletion of the cut repeat 3 and homeodomain of
CUX1 is postnatally lethal for the C3H/He or C57BL/63 129/
Sv background strain but is viable and fertile for the outbred
OF1 background, despite the absence of the CUX1 protein in
the testis [68]. These results suggest that SRC activity is not
dependent on CUX1.
We also observed a significant increase in the number of
interstitial cells in prepubertal transgenic mice. This increase
could account for the overall increase in testis size in the Cux1
transgenic mice and for the increase in testosterone levels.
While the number of interstitial cells was similar in
microscopic fields of postpubertal testes of wild-type and
transgenic mice, the overall increase in testis size suggests an
overall increase in the number of interstitial cells. The
mechanism underlying the increase in interstitial cells in the
Cux1 transgenic mice is unclear, as we did not observe ectopic
expression of CUX1 at any stage examined. One possibility is
that the number of Leydig stem cells is increased in the Cux1
transgenic mice. Further studies will be required to determine if
this is the case.
The asynchronous expression of CUX1 and alterations in
the percentage of seminiferous tubules in spermatogenic stages
in the Cux1 transgenic mice suggest that there is cross-talk
between the Sertoli cells and spermatids that affects CUX1
expression in both the spermatids and the Sertoli cells. The
process of spermatogenesis is tightly regulated, with feedback
controls to maintain adequate numbers of spermatogonia and
adequate sperm production. Sertoli cell production of GDNF
suppresses commitment of spermatogonia to meiosis and
spermiogenesis, thus maintaining numbers of spermatogonia
[69–72]. Sertoli cell expression of GDNF is regulated by both
autocrine and paracrine mechanisms, primarily by FSH, growth
factors, and cytokines, at least one of which, tumor necrosis
factor (TNF), is expressed by round spermatids [73–75]. Thus,
it is possible that expression of CUX1 beginning in round
spermatids is involved in signaling between the spermatids and
Sertoli cells. One possibility is that the increased level of
testosterone in the Cux1 transgenic mice disrupts the normal
regulation of SRC, leading to alterations in the percentage of
seminiferous tubules in spermatogenic stages. However,
numerous genes are expressed in haploid germ cells during
spermiogenesis. Indeed, of ;600 testis-specific protein-encod-
ing genes, ;350 are expressed exclusively in spermiogenesis
[76–79]. While a number of transcriptional targets of the 200-
kDa CUX1 protein have been identified, there are no known
targets of the testis-specific 55-kDa CUX1 protein. It will be
interesting to discover whether p55 functions as both a
transcriptional activator and a repressor; its structural similarity
to the p75 protein supports this possibility. Future studies
directed at identifying the targets of this protein in spermatids
will be essential to determine its function in spermiogenesis.
ACKNOWLEDGMENTS
We thank Jennifer Brantley and Rosetta Barkley for expert technical
assistance. We thank Dr. George Enders (Kansas University Medical
Center) for GCNA antibody. We thank Dr. Leslie Heckert for many helpful
discussions.
REFERENCES
1. Mruk DD, Cheng CY. Sertoli–Sertoli and Sertoli–germ cell interactions
and their significance in germ cell movement in the seminiferous
epithelium during spermatogenesis. Endocr Rev 2004; 25:747–806.
2. Hermo L, Pelletier RM, Cyr DG, Smith CE. Surfing the wave, cycle, life
history, and genes/proteins expressed by testicular germ cells. Part 1:
Background to spermatogenesis, spermatogonia, and spermatocytes.
Microsc Res Tech 2010; 73:241–278.
3. Cheng CY, Wong EW, Yan HH, Mruk DD. Regulation of spermatogen-
esis in the microenvironment of the seminiferous epithelium: new insights
and advances. Mol Cell Endocrinol 2010; 315:49–56.
4. Yan HHY, Mruk DD, Wong EWP, Lee WM, Cheng CY. An autocrine
axis in the testis that coordinates spermiation and blood–testis barrier
restructuring during spermatogenesis. Proc Natl Acad Sci U S A 2008;
105:8950–8955.
5. Byers S, Pelletier RM, Suarez-Quain C. Sertoli cell junctions and the
seminiferous epithelium barrier. In: Russell LD, Griswold MD (eds.), The
Sertoli cell. Clearwater, FL: Cache River Press; 1993:431–446.
6. Li JCH, Mruk D, Cheng CY. The inter-Sertoli tight junction permeability
barrier is regulated by the interplay of protein phosphatases and kinases:
an in vitro study. J Androl 2001; 22:847–856.
7. Lui WY, Lee WM, Cheng CY. Transforming growth factor-ß3 perturbs
the inter-Sertoli tight junction permeability barrier in vitro possibly
mediated via its effects on occludin, zonula occludens-1, and claudin-11.
Endocrinology 2001; 142:1865–1877.
8. Vogl AW, Pfeiffer DC, Mulholland D, Kimel G, Guttman J. Unique and
multifunctional adhesion junctions in the testis: ectoplasmic specializa-
tions. Arch Histol Cytol 2000; 63:1–15.
9. Risley MS, Tan IP, Roy C, Saez JC. Cell-, age-, and stage-dependent
distribution of connexin 43 gap junctions in testes. J Cell Sci 1992; 103:
81–96.
10. Tan IP, Roy C, Saez JC, Saez CG, Paul DL, Risley MS. Regulated
assembly of connexin 33 and connexin 43 into rat Sertoli cell gap
junctions. Biol Reprod 1996; 54:1300–1310.
11. Li MWM, Mruk DD, Lee WM, Cheng CY. Cytokines and junction
restructuring events during spermatogenesis in the testis: an emerging
concept of regulation. Cytokine Growth Factor Rev 2009; 20:329–338.
12. Mruk D, Zhu LJ, Silvestrini B, Lee WM, Cheng CY. Interactions of
proteases and protease inhibitors in Sertoli-germ cell cocultures preceding
the formation of specialized Sertoli-germ cell junctions in vitro. J Androl
1997; 18:612–622.
13. Mruk DD, Siu MKY, Conway AM, Lee NPY, Lau ASN, Cheng CY. Role
of tissue inhibitor of metalloprotease-1 in junction dynamics in the testis. J
Androl 2003; 24:510–523.
14. Wakayama T, Ohashi K, Mizuno K, Iseki S. Cloning and characterization
of a novel mouse immunoglobulin superfamily gene expressed in early
spermatogenic cells. Mol Reprod Dev 2001; 60:158–164.
15. Fujita E, Kouroku Y, Ozeki S, Tanabe Y, Toyama Y, Maekawa M,
Kojima N, Senoo H, Toshimori K, Momoi T. Oligo-astheno-teratozoo-
spermia in mice lacking RA175/TSLC1/SynCAM/IGSF4A, a cell
adhesion molecule in the immunoglobulin superfamily. Mol Cell Biol
2006; 26:718–726.
16. Weyden L, Arends MJ, Chausiaux OE, Ellis PJ, Lange UC, Surani MA,
Affara N, Murakami Y, Adams DJ, Bradley A. Loss of TSLC1 causes
male infertility due to a defect at the spermatid stage of spermatogenesis.
Mol Cell Biol 2006; 26:3595–3609.
17. Yamada D, Yoshida M, Williams YN, Fukami T, Kikuchi S, Masuda M,
Maruyama T, Ohta T, Nakae D, Maekawa A, Kitamura T, Murakami Y.








Disruption of spermatogenic cell adhesion and male infertility in mice
lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion
molecule. Mol Cell Biol 2006; 26:3610–3624.
18. Wakayama T, Iseki S. Role of the spermatogenic-Sertoli cell interaction
through cell adhesion molecule-1 (CADM1) in spermatogenesis. Anat Sci
Int 2009; 84:112–121.
19. Wakayama T, Sai Y, Ito A, Kato Y, Kurobo M, Murakami Y, Nakashima
E, Tsuji A, Kitamura Y, Iseki S. Heterophilic binding of the adhesion
molecules poliovirus receptor and immunoglobulin superfamily 4A in the
interaction between mouse spermatogenic and Sertoli cells. Biol Reprod
2007; 76:1081–1090.
20. Surace EI, Strickland AM, Hess RA, Gutmann DH, Naughton CK. Tslc1
(nectin-like molecule-2) is essential for spermatozoa motility and male
fertility. J Androl 2006; 27:816–825.
21. Inagaki M, Irie K, Ishizaki H, Tanaka-Okamoto M, Miyoshi J, Takai Y.
Role of cell adhesion molecule nectin-3 in spermatid development. Genes
Cells 2006; 11:1125–1132.
22. Wang Y, Lui WY. Opposite effects of interleukin-1alpha and transforming
growth factor-beta2 induce stage-specific regulation of junctional adhesion
molecule-B gene in Sertoli cells. Endocrinology 2009; 150:2404–2412.
23. Gliki G, Ebnet K, Aurrand-Lions M, Imhof BA, Adams RH. Spermatid
differentiation requires the assembly of a cell polarity complex
downstream of junctional adhesion molecule-C. Nature 2004; 431:320–
324.
24. Mirza M, Hreinsson J, Strand ML, Hovatta O, So¨der O, Philipson L,
Pettersson RF, Sollerbrant K. Coxsackievirus and adenovirus receptor
(CAR) is expressed in male germ cells and forms a complex with the
differentiation factor JAM-C in mouse testis. Exp Cell Res 2006; 312:
817–830.
25. Shibamoto S, Hayakawa M, Takeuchi K, Hori T, Oku N, Miyazawa K,
Kitamura N, Takeichi M, Ito F. Tyrosine phosphorylation of b-catenin and
plakoglobin enhanced by hepatocyte growth factor and epidermal growth
factor in human carcinoma cells. Cell Adhes Commun 1994; 1:295–305.
26. Munro SB, Blaschuk OW. A comprehensive survey of the cadherins
expressed in the testes of fetal, immature, and adult mice utilizing the
polymerase chain reaction. Biol Reprod 1996; 55:822–827.
27. Johnson KJ, Patel SR, Boekelheide K. Multiple cadherin superfamily
members with unique expression profiles are produced in rat testis.
Endocrinology 2000; 141:675–683.
28. Beardsley A, Robertson DM, O’Donnell L. A complex containing
alpha6beta1-integrin and phosphorylated focal adhesion kinase between
Sertoli cells and elongated spermatids during spermatid release from the
seminiferous epithelium. J Endocrinol 2006; 190:759–770.
29. Yan HH, Cheng CY. Laminin alpha 3 forms a complex with beta3 and
gamma3 chains that serves as the ligand for alpha 6beta1-integrin at the
apical ectoplasmic specialization in adult rat testes. J Biol Chem 2006;
281:17286–17303.
30. Orth JM, Gunsalus GL, Lamperti AA. Evidence from Sertoli cell-depleted
rats indicates that spermatid number in adults depends on numbers of
Sertoli cells produced during perinatal development. Endocrinology 1988;
122:787–794.
31. Sharpe RM, McKinnell C, Kivlin C, Fisher JS. Proliferation and functional
maturation of Sertoli cells, and their relevance to disorders of testis
function in adulthood. Reproduction 2003; 125:769–784.
32. Holsberger DR, Buchold GM, Leal MC, Kiesewetter SE, O’Brien DA,
Hess RA, Franc¸a LR, Kiyokawa H, Cooke PS. Cell-cycle inhibitors
p27Kip1 and p21Cip1 regulate murine Sertoli cell proliferation. Biol
Reprod 2005; 72:1429–1436.
33. Alcalay NI, Vanden Heuvel GB. Regulation of cell proliferation and
differentiation in the kidney. Front Biosci 2009; 14:4978–4991.
34. Andres V, Nadal-Ginard B, Mahdavi V. Clox, a mammalian homeobox
gene related to Drosophila cut, encodes DNA-binding regulatory proteins
differentially expressed during development. Development 1992; 116:
321–334.
35. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain
transcription factor in regulating differentiation, cell growth and
development. Gene 2001; 270:1–15.
36. Neufeld EJ, Skalnik DG, Lievens PM, Orkin SH. Human CCAAT
displacement protein is homologous to the Drosophila homeoprotein, cut.
Nat Genet 1992; 1:50–55.
37. Sansregret L, Nepveu A. The multiple roles of CUX1: insights from
mouse models and cell-based assays. Gene 2008; 412:84–94.
38. Vanden Heuvel GB, Bodmer R, McConnell KR, Nagami GT, Igarashi P.
Expression of a cut-related homeobox gene in developing and polycystic
mouse kidney. Kidney Int 1996; 50:453–461.
39. Yoon SO, Chikaraishi DM. Isolation of two E-box binding factors that
interact with the rat tyrosine hydroxylase enhancer. J Biol Chem 1994;
269:18453–18462.
40. Coqueret O, Berube G, Nepveu A. The mammalian Cut homeodomain
protein functions as a cell-cycle-dependent transcriptional repressor which
downmodulates p21WAF1/CIP1/SDI1 in S phase. EMBO J 1998; 17:
4680–4694.
41. Ledford AW, Brantley JG, Kemeny G, Foreman TL, Quaggin SE, Igarishi
P, Oberhaus SM, Rodova M, Calvert JP, Vanden Heuvel GB. Deregulated
expression of the homeobox gene Cux1 in transgenic mice results in
downregulation of p27kip1 expression during nephrogenesis, glomerular
abnormalities and multiorgan hyperplasia. Dev Biol 2002; 245:157–171.
42. Kedinger V, Sansregret L, Harada R, Vadnais C, Cadieux C, Fathers K,
Park M, Nepveu A. p110 CUX1 homeodomain protein stimulates cell
migration and invasion in part through a regulatory cascade culminating in
the repression of E-cadherin and occludin. J Biol Chem 2009; 284:27701–
27711.
43. Aleksic T, Bechtel M, Krndija D, von Wichert G, Knobel B, Giehl K,
Gress TM, Michl P. CUTL1 promotes tumor cell migration by decreasing
proteasome-mediated Src degradation. Oncogene 2007; 26:5939–5949.
44. Vanden Heuvel GB, Quaggin SE, Igarishi P. A unique variant of a
homeobox gene related to Drosophila cut is expressed in mouse testes.
Biol Reprod 1996; 55:731–739.
45. Goulet B, Watson P, Poirier M, Leduy L, Berube G, Meterissian S,
Jolicoeur P, Nepveu A. Characterization of a tissue-specific CDP/Cux
isoform, p75, activated in breast tumor cells. Cancer Res 2002; 62:6625–
6633.
46. Lievens PM, Tufarelli C, Donady JJ, Stagg A, Neufeld EJ. CASP, a novel,
highly conserved alternative-splicing product of the CDP/cut/cux gene,
lacks cut-repeat, and homeo DNA-binding domains, and interacts with
full-length CDP in vitro. Gene 1997; 197:73–81.
47. Goulet B, Baruch A, Moon NS, Poirier M, Sansregret LL, Erickson A,
Bogyo M, Nepveu A. A cathepsin L isoform that is devoid of a signal
peptide localizes to the nucleus in S phase and processes the CDP/Cux
transcription factor. Mol Cell 2004; 14:207–219.
48. Maitra U, Seo J, Lozano MM, Dudley JP. Differentiation-induced
cleavage of Cutl1/CDP generates a novel dominant-negative isoform that
regulates mammary gene expression. Mol Cell Biol 2006; 26:7466–7478.
49. Sharma M, Brantley JG, Alcalay NI, Zhou J, Heystek E, Maser RL,
Vanden Heuvel GB. Differential expression of Cux-1 and p21 in
polycystic kidneys from Pkd1 null and cpk mice. Kidney Int 2005; 67:
432–442.
50. Enders GC, May JJ II. Developmentally regulated expression of a mouse
germ cell nuclear antigen examined from embryonic day 11 to adult in
male and female mice. Dev Biol 1994; 163:331–340.
51. Franc¸a LR, Godinho CL. Testis morphometry, seminiferous epithelium
cycle length, and daily sperm production in domestic cats (Felis catus).
Biol Reprod 2003; 68:1554–1561.
52. Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN,
Hammer GD, Ingraham HA. Wilms’ tumor 1 and Dax-1 modulate the
orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 1998;
93:445–454.
53. Dame C, Kirschner KM, Bartz KV, Wallach T, Hussels CS, Scholz H.
Wilms tumor suppressor, Wt1, is a transcriptional activator of the
erythropoietin gene. Blood 2006; 107:4282–4290.
54. Gao F, Maiti S, Alam N, Zhang Z, Deng JM, Behringer RR, Le´cureuil C,
Guillou F, Huff V. The Wilms tumor gene, Wt1, is required for Sox9
expression and maintenance of tubular architecture in the developing
testis. Proc Natl Acad Sci U S A 2006; 103:11987–11992.
55. Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D,
Singhal P, Lele S, Odunsi K. Expression of Wilms tumor gene (WT1) in
epithelial ovarian cancer. Gynecol Oncol 2006; 101:12–17.
56. Oakberg EE. A description of spermiogenesis in the mouse and its use in
analysis of the cycle of the seminiferous epithelium and germ cell renewal.
Am J Anat 1956; 99:391–409.
57. Ahmed EA, de Rooij DG. Staging of mouse seminiferous tubule cross-
sections. Methods Mol Biol 2009; 558:263–277.
58. Walker WH. Molecular mechanisms of testosterone action in spermato-
genesis. Steroids 2009; 74:602–607.
59. Bellve´ AR, Cavicchia JC, Millette CF, O’Brien DA, Bhatnagar YM, Dym
M. Spermatogenic cells of the prepubertal mouse. Isolation and
morphological characterization. J Cell Biol 1977; 74:68–85.
60. Sharma M, Brantley JG, Vassmer D, Chaturvedi G, Baas J, Vanden
Heuvel GB. The homeodomain protein Cux1 interacts with Grg4 to
repress p27 kip1 expression during kidney development. Gene 2009; 439:
87–94.
61. Rao MK, Pham J, Imam JS, MacLean JA, Murali D, Furuta Y, Sinha-
Hikim AP, Wilkinson MF. Tissue-specific RNAi reveals that WT1








expression in nurse cells controls germ cell survival and spermatogenesis.
Genes Dev 2006; 20:147–152.
62. Yan W, Kero J, Suominen J, Toppari J. Differential expression and
regulation of the retinoblastoma family of proteins during testicular
development and spermatogenesis: roles in the control of germ cell
proliferation, differentiation and apoptosis. Oncogene 2001; 20:1343–
1356.
63. Yan HH, Mruk DD, Lee WM, Cheng CY. Blood-testis barrier dynamics
are regulated by testosterone and cytokines via their differential effects on
the kinetics of protein endocytosis and recycling in Sertoli cells. FASEB J
2008; 22:1945–1959.
64. Xia W, Wong EW, Mruk DD, Cheng CY. TGF-beta3 and TNFalpha
perturb blood-testis barrier (BTB) dynamics by accelerating the clathrin-
mediated endocytosis of integral membrane proteins: a new concept of
BTB regulation during spermatogenesis. Dev Biol 2009; 327:48–61.
65. Lee NP, Cheng CY. Protein kinases and adherence junction dynamics in
the seminiferous epithelium of the rat testis. J Cell Physiol 2005; 202:344–
360.
66. Xia W, Cheng CY. TGF-beta3 regulates anchoring junction dynamics in
the seminiferous epithelium of the rat testis via the Ras/ERK signaling
pathway: an in vivo study. Dev Biol 2005; 280:321–343.
67. Cheng J, Watkins SC, Walker WH. Testosterone activates mitogen-
activated protein kinase via Src kinase and the epidermal growth factor
receptor in sertoli cells. Endocrinology 2007; 148:2066–2074.
68. Ellis T, Gambardella L, Horcher M, Tschanz S, Capol J, Bertram P,
Jochum W, Barrandon Y, Busslinger M. The transcriptional repressor
CDP (Cutl1) is essential for epithelial cell differentiation of the lung and
the hair follicle. Genes Dev 2001; 15:2307–2319.
69. Meng X, Lindahl M, Hyvo¨nen ME, Parvinen M, de Rooij DG, Hess MW,
Raatikainen-Ahokas A, Sainio K, Rauvala H, Lakso M, Pichel JG,
Westphal H, et al. Regulation of cell fate decision of undifferentiated
spermatogonia by GDNF. Science 2000; 287:1489–1493.
70. Simon L, Ekman G, Tyagi G, Hess R, Murphy KM, Cooke P. Common
and distinct factors regulate expression of mRNA for ETV5 and GDNF.
Sertoli cell proteins essential for spermatogonial stem cell maintenance.
Exp Cell Res 2007; 313:3090–3099.
71. Tadokoro Y, Yomogida K, Ohta H, Tohda A, Nishimune Y. Homeostatic
regulation of germinal stem cell proliferation by the GDNF/FSH pathway.
Mech Dev 2002; 113:29–39.
72. Hofmann MC. Gdnf signaling pathways within the mammalian spermato-
gonial stem cell niche. Mol Cell Endocrinol 2008; 288:95–103.
73. Li MWM, Xia W, Mruk DD, Wang CQF, Yan HHN, Siu MKY, Lui WY,
Lee WM, Cheng CY. Tumor necrosis factor a reversibly disrupts the
blood–testis barrier integrity and impairs Sertoli–germ cell adhesion in the
seminiferous epithelium of adult rat testes. J Endocrinol 2006; 190:313–
329.
74. Xia W, Wong EWP, Mruk DD, Cheng CY. TGF-b3 and TNFa perturb
blood-testis barrier (BTB) dynamics by accelerating the clathrin-mediated
endocytosis of integral membrane proteins: a new concept of BTB
regulation during spermatogenesis. Dev Biol 2009; 327:48–61.
75. De SK, Chen H, Pace JL, Hunt JS, Terranova PF, Enders GC. Expression
of tumor necrosis factor-a in mouse spermatogenic cells. Endocrinology
1993; 133:389–396.
76. Lin YN, Matzuk MM. High-throughput discovery of germ-cell-specific
genes. Semin Reprod Med 2005; 23:201–212.
77. Schultz N, Hamra FK, Garbers DL. A multitude of genes expressed solely
in meiotic or postmeiotic spermatogenic cells offers a myriad of
contraceptive targets. Proc Natl Acad Sci U S A 2003; 100:12201–12206.
78. Shima JE, McLean DJ, McCarrey JR, Griswold MD. The murine testicular
transcriptome: characterizing gene expression in the testis during the
progression of spermatogenesis. Biol Reprod 2004; 71:319–330.
79. Yan W. Male infertility caused by spermiogenic defects: lessons from
gene knockouts. Mol Cell Endocrinol 2009; 306:24–32.
ASYNCHRONOUS CUX1 EXPRESSION IN SPERMATOGENESIS 465
D
ow
nloaded from
 w
w
w
.biolreprod.org. 
